Skip to main content

InterStim Micro Post Market Clinical Follow-up Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about InterStim Micro Post Market Clinical Follow-up Study

Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS

Radiotherapy for Keloids

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Radiotherapy for Keloids

Prevalence of Carbohydrate Intolerance in Lean and Obese Children

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Prevalence of Carbohydrate Intolerance in Lean and Obese Children

ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about ENRICH: Early MiNimally-invasive Removal of IntraCerebral Hemorrhage (ICH)

Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants

An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about An Intermediate Access Protocol for Selumetinib for Treatment of Neurofibromatosis Type 1

Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • Page 211
  • Page 212
  • Page 213
  • Page 214
  • …
  • Next page Next
  • Last page Last
Subscribe to